Hypoxia-regulated microRNAs in human cancer
Hypoxia plays an important role in the tumor microenvironment by allowingthe development and maintenance of cancer cells, but the regulatory mechanisms by which tumor cells adapt to hypoxic conditions are not yet well understood. MicroRNAs are recognized as a new class of master regulators that cont...
Saved in:
Published in | Acta pharmacologica Sinica Vol. 34; no. 3; pp. 336 - 341 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.03.2013
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 1671-4083 1745-7254 1745-7254 |
DOI | 10.1038/aps.2012.195 |
Cover
Abstract | Hypoxia plays an important role in the tumor microenvironment by allowingthe development and maintenance of cancer cells, but the regulatory mechanisms by which tumor cells adapt to hypoxic conditions are not yet well understood. MicroRNAs are recognized as a new class of master regulators that control gene expression and are responsible for many normal and pathological cellular processes. Studies have shown that hypoxia inducible factor 1 (HIF1) regulates a panel of microRNAs, whereas some of microRNAs target HIFI. The interaction between microRNAs and HIF1 can account for many vital events relevant to tumorigenesis, such as angiogenesis, metabolism, apoptosis, cell cycle regulation, proliferation, metastasis, and resistance to anticancer therapy. This review will summarize recent findings on the roles of hypoxia and microRNAs in human cancer and illustrate the machinery by which microRNAs interact with hypoxia in tumor cells. It is expected to update our knowledge about the regulatory roles of microRNAs in regulating tumor microenvi- ronments and thus benefit the development of new anticancer drugs. |
---|---|
AbstractList | Hypoxia plays an important role in the tumor microenvironment by allowing the development and maintenance of cancer cells, but the regulatory mechanisms by which tumor cells adapt to hypoxic conditions are not yet well understood. MicroRNAs are recognized as a new class of master regulators that control gene expression and are responsible for many normal and pathological cellular processes. Studies have shown that hypoxia inducible factor 1 (HIF1) regulates a panel of microRNAs, whereas some of microRNAs target HIF1. The interaction between microRNAs and HIF1 can account for many vital events relevant to tumorigenesis, such as angiogenesis, metabolism, apoptosis, cell cycle regulation, proliferation, metastasis, and resistance to anticancer therapy. This review will summarize recent findings on the roles of hypoxia and microRNAs in human cancer and illustrate the machinery by which microRNAs interact with hypoxia in tumor cells. It is expected to update our knowledge about the regulatory roles of microRNAs in regulating tumor microenvironments and thus benefit the development of new anticancer drugs.Hypoxia plays an important role in the tumor microenvironment by allowing the development and maintenance of cancer cells, but the regulatory mechanisms by which tumor cells adapt to hypoxic conditions are not yet well understood. MicroRNAs are recognized as a new class of master regulators that control gene expression and are responsible for many normal and pathological cellular processes. Studies have shown that hypoxia inducible factor 1 (HIF1) regulates a panel of microRNAs, whereas some of microRNAs target HIF1. The interaction between microRNAs and HIF1 can account for many vital events relevant to tumorigenesis, such as angiogenesis, metabolism, apoptosis, cell cycle regulation, proliferation, metastasis, and resistance to anticancer therapy. This review will summarize recent findings on the roles of hypoxia and microRNAs in human cancer and illustrate the machinery by which microRNAs interact with hypoxia in tumor cells. It is expected to update our knowledge about the regulatory roles of microRNAs in regulating tumor microenvironments and thus benefit the development of new anticancer drugs. Hypoxia plays an important role in the tumor microenvironment by allowing the development and maintenance of cancer cells, but the regulatory mechanisms by which tumor cells adapt to hypoxic conditions are not yet well understood. MicroRNAs are recognized as a new class of master regulators that control gene expression and are responsible for many normal and pathological cellular processes. Studies have shown that hypoxia inducible factor 1 (HIF1) regulates a panel of microRNAs, whereas some of microRNAs target HIF1. The interaction between microRNAs and HIF1 can account for many vital events relevant to tumorigenesis, such as angiogenesis, metabolism, apoptosis, cell cycle regulation, proliferation, metastasis, and resistance to anticancer therapy. This review will summarize recent findings on the roles of hypoxia and microRNAs in human cancer and illustrate the machinery by which microRNAs interact with hypoxia in tumor cells. It is expected to update our knowledge about the regulatory roles of microRNAs in regulating tumor microenvironments and thus benefit the development of new anticancer drugs. Hypoxia plays an important role in the tumor microenvironment by allowingthe development and maintenance of cancer cells, but the regulatory mechanisms by which tumor cells adapt to hypoxic conditions are not yet well understood. MicroRNAs are recognized as a new class of master regulators that control gene expression and are responsible for many normal and pathological cellular processes. Studies have shown that hypoxia inducible factor 1 (HIF1) regulates a panel of microRNAs, whereas some of microRNAs target HIFI. The interaction between microRNAs and HIF1 can account for many vital events relevant to tumorigenesis, such as angiogenesis, metabolism, apoptosis, cell cycle regulation, proliferation, metastasis, and resistance to anticancer therapy. This review will summarize recent findings on the roles of hypoxia and microRNAs in human cancer and illustrate the machinery by which microRNAs interact with hypoxia in tumor cells. It is expected to update our knowledge about the regulatory roles of microRNAs in regulating tumor microenvi- ronments and thus benefit the development of new anticancer drugs. |
Author | Guomin SHEN Xiaobo LI Yong-feng JIA Gary A PIAZZA Yaguang XI |
AuthorAffiliation | Mitchell Cancer Institute, University of South Alabama, Alabama, USA Inner Mongolia Medical University, Hohhot 010021, China |
Author_xml | – sequence: 1 givenname: Guomin surname: Shen fullname: Shen, Guomin organization: Mitchell Cancer Institute, University of South Alabama – sequence: 2 givenname: Xiaobo surname: Li fullname: Li, Xiaobo organization: Mitchell Cancer Institute, University of South Alabama – sequence: 3 givenname: Yong-feng surname: Jia fullname: Jia, Yong-feng organization: Inner Mongolia Medical University – sequence: 4 givenname: Gary A surname: Piazza fullname: Piazza, Gary A organization: Mitchell Cancer Institute, University of South Alabama – sequence: 5 givenname: Yaguang surname: Xi fullname: Xi, Yaguang email: xi@usouthal.edu organization: Mitchell Cancer Institute, University of South Alabama |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23377548$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kUtLAzEURoMovneupeJG0Kl5TpKNIOILREF0HdI000ZmkprMiP57U_tARVcJ5NzDl_ttgVUfvAVgD8E-gkSc6knqY4hwH0m2AjYRp6zgmNHVfC85KigUZANspfQCIcEEyXWwgQnhnFGxCY5vPibh3eki2lFX69YOe40zMTzen6ee871x12jfM9obG3fAWqXrZHfn5zZ4vrp8urgp7h6uby_O7wrDKG4LJIiuBDakgkPDS4spQxIJSoXWXEhLtYUMClpWlmBc0bKUFUcDLcgA0oGpyDY4m3kn3aCxQ2N9G3WtJtE1On6ooJ36-eLdWI3CmyJMcInKLDiaC2J47WxqVeOSsXWtvQ1dUoggKiQuIc_o4S_0JXTR5-99UQxxyKbC_e-JllEWe8wAngF5dSlFWynjWt26MA3oaoWgmpalcllqWpbKZeWhk19DC-8_eDHDU8b8yMZvUf_mD-b6cfCj1zyy9FNGqOQSkk9tVq47 |
CitedBy_id | crossref_primary_10_1158_1078_0432_CCR_15_0737 crossref_primary_10_1186_s13046_020_01613_y crossref_primary_10_1371_journal_pone_0141565 crossref_primary_10_1016_j_biopha_2024_116165 crossref_primary_10_1155_2016_5728438 crossref_primary_10_3390_cimb46110741 crossref_primary_10_1016_j_canlet_2016_04_011 crossref_primary_10_3390_cells11010012 crossref_primary_10_1111_cas_13791 crossref_primary_10_1007_s12094_020_02513_5 crossref_primary_10_20517_evcna_2023_52 crossref_primary_10_1152_physrev_00029_2015 crossref_primary_10_18632_genesandcancer_69 crossref_primary_10_1093_carcin_bgw050 crossref_primary_10_1016_j_gene_2019_05_038 crossref_primary_10_1186_s12943_017_0603_1 crossref_primary_10_1007_s12038_018_9789_7 crossref_primary_10_1186_s13046_018_0764_9 crossref_primary_10_3892_ijo_2015_3007 crossref_primary_10_1016_j_critrevonc_2020_103196 crossref_primary_10_1155_2020_3929435 crossref_primary_10_2217_fon_14_201 crossref_primary_10_1038_s41598_020_78242_0 crossref_primary_10_3389_fgene_2021_662468 crossref_primary_10_1016_j_gene_2017_08_006 crossref_primary_10_3390_metabo13040543 crossref_primary_10_1016_j_bioactmat_2022_07_004 crossref_primary_10_1186_s13046_020_1535_y crossref_primary_10_1097_ALN_0000000000000969 crossref_primary_10_3892_ijmm_2014_1661 crossref_primary_10_3892_ijmm_2018_4003 crossref_primary_10_1002_path_5187 crossref_primary_10_1016_j_gene_2013_07_064 crossref_primary_10_1016_j_cca_2025_120215 crossref_primary_10_1002_jcb_25059 crossref_primary_10_3390_ijms21176083 crossref_primary_10_1016_j_jare_2021_10_007 crossref_primary_10_1186_s12929_020_00658_7 crossref_primary_10_3892_or_2017_5708 crossref_primary_10_1016_j_lfs_2025_123569 crossref_primary_10_5507_bp_2015_025 crossref_primary_10_1113_JP280572 crossref_primary_10_1038_s41388_024_03129_7 crossref_primary_10_1038_srep35316 crossref_primary_10_1016_j_drudis_2018_05_003 crossref_primary_10_1007_s10695_021_01017_5 crossref_primary_10_1016_j_semcancer_2020_09_002 crossref_primary_10_1016_j_lfs_2015_07_002 crossref_primary_10_1016_j_omto_2021_06_015 crossref_primary_10_1016_j_canlet_2020_06_024 crossref_primary_10_1038_s41416_021_01326_9 crossref_primary_10_18632_oncotarget_3604 crossref_primary_10_1016_j_mam_2016_01_003 crossref_primary_10_3892_ijo_2018_4285 crossref_primary_10_18632_aging_202542 crossref_primary_10_3390_ijms19113378 crossref_primary_10_1080_10409238_2022_2088684 crossref_primary_10_1371_journal_pone_0080844 crossref_primary_10_1016_j_bbcan_2015_02_001 crossref_primary_10_3892_ijo_2015_3056 crossref_primary_10_1038_s41598_020_60935_1 crossref_primary_10_1155_2024_9347381 crossref_primary_10_1016_j_febslet_2014_05_067 crossref_primary_10_1371_journal_pone_0113050 crossref_primary_10_1177_1535370215610442 crossref_primary_10_1371_journal_pcbi_1004217 crossref_primary_10_3390_jcm8020130 crossref_primary_10_1186_s12935_023_03086_3 crossref_primary_10_3390_jcm13247644 crossref_primary_10_1186_1471_2164_15_686 crossref_primary_10_3389_fonc_2019_01404 crossref_primary_10_1016_j_yexmp_2020_104592 crossref_primary_10_3724_abbs_2023231 crossref_primary_10_1038_s41598_022_12566_x crossref_primary_10_1186_s12885_017_3140_9 crossref_primary_10_1007_s00432_019_02940_0 crossref_primary_10_1186_s12885_021_08978_z crossref_primary_10_1016_j_omtn_2019_09_002 crossref_primary_10_24075_brsmu_2020_074 crossref_primary_10_3892_ol_2015_3344 crossref_primary_10_3390_cells10123311 crossref_primary_10_3390_ijms24043496 crossref_primary_10_3389_fonc_2021_708765 crossref_primary_10_3390_biom12050686 crossref_primary_10_1158_1940_6207_CAPR_13_0032 crossref_primary_10_3390_antiox13111326 crossref_primary_10_1021_es504676s crossref_primary_10_1634_theoncologist_2019_0497 crossref_primary_10_3389_fcell_2019_00004 crossref_primary_10_3389_fimmu_2022_913951 crossref_primary_10_1111_1346_8138_12314 crossref_primary_10_1016_j_envpol_2020_115597 crossref_primary_10_3171_2015_8_JNS15437 crossref_primary_10_1186_1471_2407_14_429 crossref_primary_10_1016_j_canlet_2019_02_030 crossref_primary_10_1002_gcc_22244 crossref_primary_10_1186_s13046_020_01824_3 crossref_primary_10_1080_20013078_2019_1567219 crossref_primary_10_1080_07357907_2016_1245317 crossref_primary_10_47529_2223_2524_2023_4_8 crossref_primary_10_1002_wrna_1820 crossref_primary_10_1016_j_genrep_2021_101408 crossref_primary_10_3389_fonc_2021_683725 crossref_primary_10_1155_2024_5523283 crossref_primary_10_1080_08941939_2016_1206999 crossref_primary_10_1038_cmi_2014_45 crossref_primary_10_3389_fphar_2020_00013 crossref_primary_10_1371_journal_pone_0164976 crossref_primary_10_1186_s12903_022_02425_6 crossref_primary_10_1016_j_intimp_2022_109040 crossref_primary_10_3390_cells9122598 crossref_primary_10_3389_fphar_2022_844104 crossref_primary_10_3892_ol_2017_7636 crossref_primary_10_1002_wrna_1676 crossref_primary_10_1111_cpr_12264 crossref_primary_10_3390_ijms20194799 crossref_primary_10_1002_jcp_26347 crossref_primary_10_18632_oncotarget_11772 crossref_primary_10_3390_genes16020140 crossref_primary_10_3389_fphar_2022_860898 crossref_primary_10_1038_onc_2014_254 |
Cites_doi | 10.1093/bioinformatics/btr180 10.1158/0008-5472.CAN-12-0667 10.1038/nature03677 10.1128/MCB.16.9.4604 10.1016/j.ccr.2007.04.001 10.1038/nrc909 10.4161/cbt.7.2.5297 10.1038/emboj.2009.214 10.1161/01.RES.0000102937.50486.1B 10.1038/onc.2010.23 10.1158/0008-5472.CAN-11-0365 10.1128/MCB.05776-11 10.1371/journal.pone.0037537 10.1016/S0076-6879(04)81023-1 10.4161/cc.9.6.11006 10.1038/onc.2011.655 10.1371/journal.pone.0017167 10.2217/14796694.1.6.779 10.1371/journal.pone.0007629 10.1128/MCB.01242-10 10.1186/bcr2720 10.1074/jbc.M110.109207 10.1074/jbc.M111.284158 10.1158/0008-5472.CAN-08-2516 10.1074/jbc.M110.158790 10.1038/nbt.1618 10.1172/JCI42980 10.1038/cdd.2010.119 10.1371/journal.pone.0019139 10.1074/jbc.M109.020925 10.1016/S1471-4914(02)02317-1 10.4161/cc.8.17.9387 10.1007/s00424-010-0910-5 10.1046/j.1432-1033.2003.03846.x 10.1186/1741-7015-8-64 10.1016/j.molmed.2010.03.004 10.1016/j.yexcr.2012.02.010 10.1002/hep.24614 10.1074/jbc.M109.052779 10.1038/onc.2010.193 10.1158/0008-5472.CAN-12-1383 10.1093/bioinformatics/btp655 10.1016/j.cmet.2009.05.005 10.1002/jcp.21558 10.1016/j.cmet.2009.08.015 10.1128/MCB.01395-06 10.1038/ncb1691 10.1073/pnas.0911082107 10.1074/jbc.M800731200 10.1158/0008-5472.CAN-10-3320 10.1074/jbc.C600252200 10.1158/0008-5472.CAN-07-6460 10.1111/j.1440-1746.2007.04997.x 10.1371/journal.pone.0010345 10.1128/MCB.01276-10 10.1038/nm1075 10.1056/NEJMra0706596 10.1111/j.1582-4934.2011.01484.x 10.1161/CIRCRESAHA.108.193102 10.1016/j.molcel.2009.09.006 10.1038/74651 10.1093/cvr/cvq082 10.1158/0008-5472.CAN-09-2448 10.1002/jcp.22126 |
ContentType | Journal Article |
Copyright | The Author(s) 2013 Copyright Nature Publishing Group Mar 2013 Copyright © 2013 CPS and SIMM 2013 CPS and SIMM |
Copyright_xml | – notice: The Author(s) 2013 – notice: Copyright Nature Publishing Group Mar 2013 – notice: Copyright © 2013 CPS and SIMM 2013 CPS and SIMM |
DBID | 2RA 92L CQIGP W91 ~WA C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7QR 7T5 7TK 7TO 7U9 7X7 7XB 88E 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7N M7P P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1038/aps.2012.195 |
DatabaseName | 维普_期刊 中文科技期刊数据库-CALIS站点 中文科技期刊数据库-7.0平台 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Neurosciences Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Engineering Research Database ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Biotechnology and BioEngineering Abstracts Proquest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Oncogenes and Growth Factors Abstracts Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Central Student |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals (WRLC) url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | Hypoxia-regulated microRNAs in human cancer |
EISSN | 1745-7254 |
EndPage | 341 |
ExternalDocumentID | PMC3587916 2907523331 23377548 10_1038_aps_2012_195 45349790 |
Genre | Journal Article Review Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: R21 CA160280 – fundername: NCI NIH HHS grantid: 1R21CA160280-01A1 |
GroupedDBID | --- -05 -0E -Q- -S~ .3N 0R~ 188 1OC 23M 2RA 2WC 31~ 36B 3V. 4.4 406 53G 5GY 5VR 5VS 6J9 70F 7X7 8-1 88E 8FI 8FJ 8R4 8R5 8RM 92L 92M 9D9 9DE A8Z AADWK AANZL AATNV AAWBL AAYFA AAYJO AAZLF ABAWZ ABGIJ ABKZE ABUWG ACAOD ACBMV ACBRV ACBYP ACGFO ACGFS ACIGE ACIWK ACKTT ACPRK ACRQY ACTTH ACVWB ACXQS ACZOJ ADBBV ADFRT ADHDB ADMDM ADQMX ADRAZ ADYYL AEDAW AEFTE AEJRE AENEX AESKC AEVLU AEXYK AFBPY AFKRA AFNRJ AFRAH AFSHS AFUIB AFZJQ AGAYW AGEZK AGGBP AGHAI AHMBA AHSBF AILAN AJAOE AJCLW AJDOV AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS AMRJV AMYLF AOIJS AXYYD BAWUL BBNVY BENPR BFHJK BHPHI BKKNO BPHCQ BVXVI C1A CAG CAJEE CAJUS CCEZO CCPQU CHBEP CIEJG CO8 COF CQIGP CS3 CW9 DIK DNIVK DPUIP E3Z EBLON EBS EE. EIOEI EJD EMB EMOBN ESTFP F5P FA0 FDQFY FERAY FIZPM FSGXE FYUFA GX1 HCIFZ HH5 HMCUK HYE HZI HZ~ IWAJR JSO JUIAU JZLTJ K97 KQ8 LH4 LW6 M1P M48 M7P MK0 NQJWS NXXTH NYICJ O9- OK1 OVD P2P P6G PQQKQ PROAC PSQYO Q-- Q-4 Q2X R-E RNT RNTTT RPM RT5 S.. SNX SNYQT SOHCF SRMVM SV3 SWTZT T8U TAOOD TBHMF TDRGL TEORI TR2 TSG U1F U1G U5E U5O UKHRP UZ5 W91 ~88 ~NG ~WA -SE AACDK AASML AAXDM ABAKF ABZZP ACMJI AEFQL AEMSY AFBBN AGQEE AIGIU ALIPV C6C FIGPU LGEZI LOTEE NADUK ROL AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC AEZWR AFDZB AFHIU AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT SOJ ABRTQ CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 7QP 7QR 7T5 7TK 7TO 7U9 7XB 8FD 8FE 8FH 8FK AZQEC DWQXO FR3 GNUQQ H94 K9. LK8 M7N P64 PKEHL PQEST PQUKI PRINS 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c542t-183af82c3f0dc76e2451918448aa789e4ae050846fe322f4669f71ba83b04bcf3 |
IEDL.DBID | M48 |
ISSN | 1671-4083 1745-7254 |
IngestDate | Thu Aug 21 17:32:45 EDT 2025 Thu Sep 04 16:08:13 EDT 2025 Fri Jul 25 08:58:00 EDT 2025 Mon Jul 21 06:00:57 EDT 2025 Tue Jul 01 02:04:11 EDT 2025 Thu Apr 24 22:57:21 EDT 2025 Fri Feb 21 02:38:48 EST 2025 Wed Feb 14 11:03:29 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | hypoxia chemoresistance human cancer cell cycle angiogenesis microRNA apoptosis HIF1 radioresistance cancer metastasis |
Language | English |
License | https://creativecommons.org/licenses/by-nc-nd/3.0 This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c542t-183af82c3f0dc76e2451918448aa789e4ae050846fe322f4669f71ba83b04bcf3 |
Notes | microRNA; hypoxia; HIF1; human cancer; angiogenesis; apoptosis; cell cycle; cancer metastasis; chemoresistance; radiore-sistance Hypoxia plays an important role in the tumor microenvironment by allowingthe development and maintenance of cancer cells, but the regulatory mechanisms by which tumor cells adapt to hypoxic conditions are not yet well understood. MicroRNAs are recognized as a new class of master regulators that control gene expression and are responsible for many normal and pathological cellular processes. Studies have shown that hypoxia inducible factor 1 (HIF1) regulates a panel of microRNAs, whereas some of microRNAs target HIFI. The interaction between microRNAs and HIF1 can account for many vital events relevant to tumorigenesis, such as angiogenesis, metabolism, apoptosis, cell cycle regulation, proliferation, metastasis, and resistance to anticancer therapy. This review will summarize recent findings on the roles of hypoxia and microRNAs in human cancer and illustrate the machinery by which microRNAs interact with hypoxia in tumor cells. It is expected to update our knowledge about the regulatory roles of microRNAs in regulating tumor microenvi- ronments and thus benefit the development of new anticancer drugs. 31-1347/R ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/aps.2012.195 |
PMID | 23377548 |
PQID | 1314517056 |
PQPubID | 28815 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3587916 proquest_miscellaneous_1314892607 proquest_journals_1314517056 pubmed_primary_23377548 crossref_citationtrail_10_1038_aps_2012_195 crossref_primary_10_1038_aps_2012_195 springer_journals_10_1038_aps_2012_195 chongqing_primary_45349790 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-03-01 |
PublicationDateYYYYMMDD | 2013-03-01 |
PublicationDate_xml | – month: 03 year: 2013 text: 2013-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: United States – name: Shanghai |
PublicationTitle | Acta pharmacologica Sinica |
PublicationTitleAbbrev | Acta Pharmacol Sin |
PublicationTitleAlternate | Acta Pharmacologica Sinica |
PublicationYear | 2013 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Chen, Lin, Chung, Lang, Lin, Huang (CR61) 2012; 72 Kulshreshtha, Ferracin, Wojcik, Garzon, Alder, Agosto-Perez (CR22) 2007; 27 Zhang, Gao, Fukuda, Kumar, Krishnamachary, Zeller (CR49) 2007; 11 Li, Gao, Cui, Gary, Dyess, Taylor (CR26) 2012; 31 Kim, Haider, Jiang, Ashraf (CR56) 2009; 284 Wu, Xie, Chen (CR62) 2007; 22 Zhu, Chen, Luo, Guan, Zhang, Zhang (CR64) 2005; 24 Chen, Li, Zhang, Huang, Luthra (CR53) 2010; 29 Haque, Banerjee, Mehta, De, Majumder, Mayo (CR8) 2011; 286 Taguchi, Yanagisawa, Tanaka, Cao, Matsuyama, Goto (CR35) 2008; 68 Chan, Loscalzo (CR15) 2010; 9 Ying, Liang, Guo, Zha, Tian, Huang (CR60) 2011; 54 Zhang, Sun, Dai, Walsh, Imakura, Schelter (CR59) 2009; 8 Ferrara (CR40) 2002; 2 Cha, Chen, Johansson, Chu, Wang, Jeng (CR37) 2010; 70 Carmeliet (CR39) 2000; 6 Pocock (CR4) 2011; 461 Ma, Reinhardt, Pan, Soutschek, Bhat, Marcusson (CR28) 2010; 28 Yamakuchi, Lotterman, Bao, Hruban, Karim, Mendell (CR38) 2010; 107 Wang, Wang, Howell, Qian, Huang, Riker (CR17) 2010; 26 Ma (CR27) 2010; 12 Kerbel (CR41) 2008; 358 Vaupel, Mayer, Hockel (CR2) 2004; 381 Bruning, Cerone, Neufeld, Fitzpatrick, Cheong, Scholz (CR6) 2011; 31 Semenza (CR3) 2002; 8 Forsythe, Jiang, Iyer, Agani, Leung, Koos (CR42) 1996; 16 Cascio, D'Andrea, Ferla, Surmacz, Gulotta, Amodeo (CR47) 2010; 224 Crosby, Kulshreshtha, Ivan, Glazer (CR7) 2009; 69 Neal, Michael, Rawlings, Van der Hoek, Gleadle (CR10) 2010; 8 Wang, Howel, Bruheim, Ju, Owen, Fodstad (CR16) 2011; 6 Giannakakis, Sandaltzopoulos, Greshock, Liang, Huang, Hasegawa (CR54) 2008; 7 Cheng, Zhu, Yang, Liu, Dong, Wang (CR57) 2010; 87 Simon, Tournaire, Pouyssegur (CR43) 2008; 217 Yang, Sun, Cao, Liu, Tian, Zhu (CR65) 2012; 318 De Milito, Fais (CR63) 2005; 1 Huang, Le, Giaccia (CR14) 2010; 16 Zhang, Shen, Liu, Wang, Zhao, Zhang (CR25) 2012; 16 Yang, Wu, Chiou, Chen, Chang, Liu (CR23) 2008; 10 Kelly, Hackett, Hirota, Oshima, Cai, Berg-Dixon (CR45) 2003; 93 Fasanaro, D'Alessandra, Di Stefano, Melchionna, Romani, Pompilio (CR46) 2008; 283 Krishnan, Suter, Windak, Krebs, Felley, Montessuit (CR24) 2009; 9 Puissegur, Mazure, Bertero, Pradelli, Grosso, Robbe-Sermesant (CR55) 2011; 18 Liu, Li, Chen, Jing, Carpenter, Jiang (CR48) 2011; 6 Fasanaro, Greco, Lorenzi, Pescatori, Brioschi, Kulshreshtha (CR51) 2009; 284 Sayed, He, Hong, Gao, Rane, Yang (CR58) 2010; 285 Yan, Xue, Mei, Wang, Ding, Liu (CR29) 2009; 28 Mathieu, Zhang, Zhou, Wang, Heddleston, Pinna (CR9) 2011; 71 Wang, Zhang, Wang, Tan, Xi (CR19) 2012; 7 Hofbauer, Gess, Lohaus, Meyer, Katschinski, Kurtz (CR32) 2003; 270 Noman, Buart, Romero, Ketari, Janji, Mari (CR1) 2012; 72 Chan, Zhang, Hemann, Mahoney, Zweier, Loscalzo (CR50) 2009; 10 Lei, Li, Yang, Fang, Zhang, Feng (CR13) 2009; 4 Ceradini, Kulkarni, Callaghan, Tepper, Bastidas, Kleinman (CR44) 2004; 10 Chan, Khanna, Roy, Sen (CR12) 2011; 286 Wang, Wang, Xi (CR18) 2011; 27 Rane, He, Sayed, Vashistha, Malhotra, Sadoshima (CR36) 2009; 104 Woods, Thomson, Hammond (CR21) 2007; 282 Kelly, Souza, Clish, Puigserver (CR33) 2011; 31 Polytarchou, Iliopoulos, Hatziapostolou, Kottakis, Maroulakou, Struhl (CR30) 2011; 71 Favaro, Ramachandran, McCormick, Gee, Blancher, Crosby (CR52) 2010; 5 Loayza-Puch, Yoshida, Matsuzaki, Takahashi, Kitayama, Noda (CR11) 2010; 29 Ghosh, Subramanian, Adhikari, Zhang, Joshi, Basi (CR34) 2010; 120 O'Donnell, Wentzel, Zeller, Dang, Mendell (CR20) 2005; 435 Wu, So, Davis-Dusenbery, Qi, Bloch, Shi (CR31) 2011; 31 Huang, Ding, Bennewith, Tong, Welford, Ang (CR5) 2009; 35 W Yang (BFaps2012195_CR65) 2012; 318 R Kulshreshtha (BFaps2012195_CR22) 2007; 27 SY Chan (BFaps2012195_CR15) 2010; 9 B Wang (BFaps2012195_CR17) 2010; 26 H Zhang (BFaps2012195_CR49) 2007; 11 TJ Kelly (BFaps2012195_CR33) 2011; 31 YC Chan (BFaps2012195_CR12) 2011; 286 S Rane (BFaps2012195_CR36) 2009; 104 P Carmeliet (BFaps2012195_CR39) 2000; 6 N Ferrara (BFaps2012195_CR40) 2002; 2 X Li (BFaps2012195_CR26) 2012; 31 A De Milito (BFaps2012195_CR63) 2005; 1 MZ Noman (BFaps2012195_CR1) 2012; 72 S Cascio (BFaps2012195_CR47) 2010; 224 R Pocock (BFaps2012195_CR4) 2011; 461 X Huang (BFaps2012195_CR14) 2010; 16 HY Chen (BFaps2012195_CR61) 2012; 72 B Wang (BFaps2012195_CR16) 2011; 6 M Yamakuchi (BFaps2012195_CR38) 2010; 107 E Favaro (BFaps2012195_CR52) 2010; 5 KH Hofbauer (BFaps2012195_CR32) 2003; 270 MP Puissegur (BFaps2012195_CR55) 2011; 18 U Bruning (BFaps2012195_CR6) 2011; 31 LZ Liu (BFaps2012195_CR48) 2011; 6 ME Crosby (BFaps2012195_CR7) 2009; 69 G Ghosh (BFaps2012195_CR34) 2010; 120 KA O'Donnell (BFaps2012195_CR20) 2005; 435 L Ma (BFaps2012195_CR27) 2010; 12 FL Zhang (BFaps2012195_CR25) 2012; 16 P Vaupel (BFaps2012195_CR2) 2004; 381 B Wang (BFaps2012195_CR19) 2012; 7 ST Cha (BFaps2012195_CR37) 2010; 70 HW Kim (BFaps2012195_CR56) 2009; 284 I Haque (BFaps2012195_CR8) 2011; 286 Z Lei (BFaps2012195_CR13) 2009; 4 Z Zhang (BFaps2012195_CR59) 2009; 8 P Fasanaro (BFaps2012195_CR46) 2008; 283 A Taguchi (BFaps2012195_CR35) 2008; 68 C Wu (BFaps2012195_CR31) 2011; 31 MP Simon (BFaps2012195_CR43) 2008; 217 C Polytarchou (BFaps2012195_CR30) 2011; 71 Z Chen (BFaps2012195_CR53) 2010; 29 B Wang (BFaps2012195_CR18) 2011; 27 DJ Ceradini (BFaps2012195_CR44) 2004; 10 F Loayza-Puch (BFaps2012195_CR11) 2010; 29 J Mathieu (BFaps2012195_CR9) 2011; 71 H Zhu (BFaps2012195_CR64) 2005; 24 RS Kerbel (BFaps2012195_CR41) 2008; 358 MH Yang (BFaps2012195_CR23) 2008; 10 CS Neal (BFaps2012195_CR10) 2010; 8 GL Semenza (BFaps2012195_CR3) 2002; 8 L Ma (BFaps2012195_CR28) 2010; 28 BD Kelly (BFaps2012195_CR45) 2003; 93 Q Ying (BFaps2012195_CR60) 2011; 54 A Giannakakis (BFaps2012195_CR54) 2008; 7 HL Yan (BFaps2012195_CR29) 2009; 28 P Fasanaro (BFaps2012195_CR51) 2009; 284 K Woods (BFaps2012195_CR21) 2007; 282 SY Chan (BFaps2012195_CR50) 2009; 10 Y Cheng (BFaps2012195_CR57) 2010; 87 XZ Wu (BFaps2012195_CR62) 2007; 22 JA Forsythe (BFaps2012195_CR42) 1996; 16 D Sayed (BFaps2012195_CR58) 2010; 285 J Krishnan (BFaps2012195_CR24) 2009; 9 X Huang (BFaps2012195_CR5) 2009; 35 18463380 - N Engl J Med. 2008 May 8;358(19):2039-49 20219857 - Cardiovasc Res. 2010 Aug 1;87(3):431-9 18297062 - Nat Cell Biol. 2008 Mar;10(3):295-305 22286762 - Oncogene. 2012 Nov 29;31(48):4979-86 20434954 - Trends Mol Med. 2010 May;16(5):230-7 17482131 - Cancer Cell. 2007 May;11(5):407-20 22144109 - Hepatology. 2011 Dec;54(6):2064-75 14622280 - Eur J Biochem. 2003 Nov;270(22):4515-22 17194750 - Mol Cell Biol. 2007 Mar;27(5):1859-67 18059191 - Cancer Biol Ther. 2008 Feb;7(2):255-64 20308559 - Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6334-9 21555366 - Cancer Res. 2011 Jul 1;71(13):4720-31 21544242 - PLoS One. 2011;6(4):e19139 19265035 - Circ Res. 2009 Apr 10;104(7):879-86 20232316 - J Cell Physiol. 2010 Jul;224(1):242-9 21807897 - Mol Cell Biol. 2011 Oct;31(19):4087-96 20972335 - J Clin Invest. 2010 Nov;120(11):4141-54 21969601 - Mol Cell Biol. 2011 Dec;31(23):4760-74 21081489 - J Biol Chem. 2011 Jan 21;286(3):2047-56 22962263 - Cancer Res. 2012 Sep 15;72(18):4629-41 17559361 - J Gastroenterol Hepatol. 2007 Aug;22(8):1178-82 20964835 - BMC Med. 2010;8:64 20351690 - Nat Biotechnol. 2010 Apr;28(4):341-7 18720385 - J Cell Physiol. 2008 Dec;217(3):809-18 20237418 - Cell Cycle. 2010 Mar 15;9(6):1072-83 15063685 - Methods Enzymol. 2004;381:335-54 15944709 - Nature. 2005 Jun 9;435(7043):839-43 19721136 - J Biol Chem. 2009 Nov 27;284(48):33161-8 8756616 - Mol Cell Biol. 1996 Sep;16(9):4604-13 19652553 - Cell Cycle. 2009 Sep 1;8(17):2756-68 16471319 - J Exp Clin Cancer Res. 2005 Dec;24(4):565-74 19933824 - Bioinformatics. 2010 Jan 15;26(2):228-34 22050843 - J Cell Mol Med. 2012 Aug;16(8):1889-99 15235597 - Nat Med. 2004 Aug;10(8):858-64 21712410 - Cancer Res. 2011 Jul 1;71(13):4640-52 19141645 - Cancer Res. 2009 Feb 1;69(3):1221-9 22655055 - PLoS One. 2012;7(5):e37537 19782034 - Mol Cell. 2009 Sep 24;35(6):856-67 20154725 - Oncogene. 2010 May 6;29(18):2638-48 21207057 - Pflugers Arch. 2011 Mar;461(3):307-15 14576200 - Circ Res. 2003 Nov 28;93(11):1074-81 19808020 - Cell Metab. 2009 Oct;10(4):273-84 21067538 - Breast Cancer Res. 2010;12(5):210 22593189 - Cancer Res. 2012 Jul 15;72(14):3631-41 10742145 - Nat Med. 2000 Apr;6(4):389-95 19490906 - Cell Metab. 2009 Jun;9(6):512-24 19826008 - J Biol Chem. 2009 Dec 11;284(50):35134-43 22020939 - J Biol Chem. 2011 Dec 16;286(50):43475-85 18632605 - Cancer Res. 2008 Jul 15;68(14):5540-5 12360282 - Nat Rev Cancer. 2002 Oct;2(10):795-803 11927290 - Trends Mol Med. 2002;8(4 Suppl):S62-7 21498399 - Bioinformatics. 2011 Jun 1;27(11):1506-12 19893619 - PLoS One. 2009;4(10):e7629 20498629 - Oncogene. 2010 Jul 29;29(30):4362-8 18417479 - J Biol Chem. 2008 Jun 6;283(23):15878-83 20436681 - PLoS One. 2010;5(4):e10345 17135268 - J Biol Chem. 2007 Jan 26;282(4):2130-4 20885442 - Cell Death Differ. 2011 Mar;18(3):465-78 20404348 - J Biol Chem. 2010 Jun 25;285(26):20281-90 21347261 - PLoS One. 2011;6(2):e17167 22387901 - Exp Cell Res. 2012 May 1;318(8):944-54 16556057 - Future Oncol. 2005 Dec;1(6):779-86 21555452 - Mol Cell Biol. 2011 Jul;31(13):2696-706 19696742 - EMBO J. 2009 Sep 16;28(18):2719-32 20233879 - Cancer Res. 2010 Apr 1;70(7):2675-85 |
References_xml | – volume: 27 start-page: 1506 year: 2011 end-page: 12 ident: CR18 article-title: Normalizing bead-based microRNA expression data: a measurement error model-based approach publication-title: Bioinformatics doi: 10.1093/bioinformatics/btr180 – volume: 72 start-page: 3631 year: 2012 end-page: 41 ident: CR61 article-title: miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-12-0667 – volume: 435 start-page: 839 year: 2005 end-page: 43 ident: CR20 article-title: c-Myc-regulated microRNAs modulate E2F1 expression publication-title: Nature doi: 10.1038/nature03677 – volume: 16 start-page: 4604 year: 1996 end-page: 13 ident: CR42 article-title: Activation of vascular endothelial growth factor gene transcription by hypoxia–inducible factor 1 publication-title: Mol Cell Biol doi: 10.1128/MCB.16.9.4604 – volume: 11 start-page: 407 year: 2007 end-page: 20 ident: CR49 article-title: HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity publication-title: Cancer Cell doi: 10.1016/j.ccr.2007.04.001 – volume: 2 start-page: 795 year: 2002 end-page: 803 ident: CR40 article-title: VEGF and the quest for tumour angiogenesis factors publication-title: Nat Rev Cancer doi: 10.1038/nrc909 – volume: 7 start-page: 255 year: 2008 end-page: 64 ident: CR54 article-title: miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer publication-title: Cancer Biol Ther doi: 10.4161/cbt.7.2.5297 – volume: 28 start-page: 2719 year: 2009 end-page: 32 ident: CR29 article-title: Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis publication-title: EMBO J doi: 10.1038/emboj.2009.214 – volume: 93 start-page: 1074 year: 2003 end-page: 81 ident: CR45 article-title: Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1 publication-title: Circ Res doi: 10.1161/01.RES.0000102937.50486.1B – volume: 29 start-page: 2638 year: 2010 end-page: 48 ident: CR11 article-title: Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs publication-title: Oncogene doi: 10.1038/onc.2010.23 – volume: 71 start-page: 4720 year: 2011 end-page: 31 ident: CR30 article-title: Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-11-0365 – volume: 31 start-page: 4760 year: 2011 end-page: 74 ident: CR31 article-title: Hypoxia potentiates microRNA-mediated gene silencing through posttranslational modification of Argonaute2 publication-title: Mol Cell Biol doi: 10.1128/MCB.05776-11 – volume: 7 start-page: e37537 year: 2012 ident: CR19 article-title: Testing for differentially-expressed microRNAs with errors-in-variables nonparametric regression publication-title: PLoS One doi: 10.1371/journal.pone.0037537 – volume: 381 start-page: 335 year: 2004 end-page: 54 ident: CR2 article-title: Tumor hypoxia and malignant progression publication-title: Methods Enzymol doi: 10.1016/S0076-6879(04)81023-1 – volume: 9 start-page: 1072 year: 2010 end-page: 83 ident: CR15 article-title: MicroRNA-210: a unique and pleiotropic hypoxamir publication-title: Cell Cycle doi: 10.4161/cc.9.6.11006 – volume: 31 start-page: 4979 year: 2012 end-page: 86 ident: CR26 article-title: Sulindac inhibits tumor cell invasion by suppressing NF-kappaB-mediated transcription of microRNAs publication-title: Oncogene doi: 10.1038/onc.2011.655 – volume: 6 start-page: e17167 year: 2011 ident: CR16 article-title: Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array publication-title: PLoS One doi: 10.1371/journal.pone.0017167 – volume: 1 start-page: 779 year: 2005 end-page: 86 ident: CR63 article-title: Tumor acidity, chemoresistance and proton pump inhibitors publication-title: Future Oncol doi: 10.2217/14796694.1.6.779 – volume: 4 start-page: e7629 year: 2009 ident: CR13 article-title: Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration publication-title: PLoS One doi: 10.1371/journal.pone.0007629 – volume: 31 start-page: 2696 year: 2011 end-page: 706 ident: CR33 article-title: A hypoxia-induced positive feedback loop promotes hypoxia-inducible factor 1alpha stability through miR-210 suppression of glycerol-3-phosphate dehydrogenase 1-like publication-title: Mol Cell Biol doi: 10.1128/MCB.01242-10 – volume: 12 start-page: 210 year: 2010 ident: CR27 article-title: Role of miR-10b in breast cancer metastasis publication-title: Breast Cancer Res doi: 10.1186/bcr2720 – volume: 285 start-page: 20281 year: 2010 end-page: 90 ident: CR58 article-title: MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand publication-title: J Biol Chem doi: 10.1074/jbc.M110.109207 – volume: 286 start-page: 43475 year: 2011 end-page: 85 ident: CR8 article-title: Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1alpha-TWIST signaling networks in human breast cancer cells publication-title: J Biol Chem doi: 10.1074/jbc.M111.284158 – volume: 69 start-page: 1221 year: 2009 end-page: 9 ident: CR7 article-title: MicroRNA regulation of DNA repair gene expression in hypoxic stress publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-2516 – volume: 286 start-page: 2047 year: 2011 end-page: 56 ident: CR12 article-title: miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells publication-title: J Biol Chem doi: 10.1074/jbc.M110.158790 – volume: 28 start-page: 341 year: 2010 end-page: 7 ident: CR28 article-title: Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model publication-title: Nature Biotechnol doi: 10.1038/nbt.1618 – volume: 120 start-page: 4141 year: 2010 end-page: 54 ident: CR34 article-title: Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-alpha isoforms and promotes angiogenesis publication-title: J Clin Invest doi: 10.1172/JCI42980 – volume: 18 start-page: 465 year: 2011 end-page: 78 ident: CR55 article-title: miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity publication-title: Cell Death Differ doi: 10.1038/cdd.2010.119 – volume: 6 start-page: e19139 year: 2011 ident: CR48 article-title: MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression publication-title: PLoS One doi: 10.1371/journal.pone.0019139 – volume: 284 start-page: 33161 year: 2009 end-page: 8 ident: CR56 article-title: Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2 publication-title: J Biol Chem doi: 10.1074/jbc.M109.020925 – volume: 8 start-page: S62 year: 2002 end-page: 7 ident: CR3 article-title: HIF-1 and tumor progression: pathophysiology and therapeutics publication-title: Trends Mol Med doi: 10.1016/S1471-4914(02)02317-1 – volume: 8 start-page: 2756 year: 2009 end-page: 68 ident: CR59 article-title: MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT publication-title: Cell Cycle doi: 10.4161/cc.8.17.9387 – volume: 461 start-page: 307 year: 2011 end-page: 15 ident: CR4 article-title: Invited review: decoding the microRNA response to hypoxia publication-title: Pflugers Arch doi: 10.1007/s00424-010-0910-5 – volume: 270 start-page: 4515 year: 2003 end-page: 22 ident: CR32 article-title: Oxygen tension regulates the expression of a group of procollagen hydroxylases publication-title: Eur J Biochem doi: 10.1046/j.1432-1033.2003.03846.x – volume: 8 start-page: 64 year: 2010 ident: CR10 article-title: The VHL-dependent regulation of microRNAs in renal cancer publication-title: BMC Med doi: 10.1186/1741-7015-8-64 – volume: 16 start-page: 230 year: 2010 end-page: 7 ident: CR14 article-title: MiR-210 — micromanager of the hypoxia pathway publication-title: Trends Mol Med doi: 10.1016/j.molmed.2010.03.004 – volume: 318 start-page: 944 year: 2012 end-page: 54 ident: CR65 article-title: Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2012.02.010 – volume: 54 start-page: 2064 year: 2011 end-page: 75 ident: CR60 article-title: Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma publication-title: Hepatology doi: 10.1002/hep.24614 – volume: 284 start-page: 35134 year: 2009 end-page: 43 ident: CR51 article-title: An integrated approach for experimental target identification of hypoxia-induced miR-210 publication-title: J Biol Chem doi: 10.1074/jbc.M109.052779 – volume: 29 start-page: 4362 year: 2010 end-page: 8 ident: CR53 article-title: Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression publication-title: Oncogene doi: 10.1038/onc.2010.193 – volume: 72 start-page: 4629 year: 2012 end-page: 41 ident: CR1 article-title: Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-12-1383 – volume: 26 start-page: 228 year: 2010 end-page: 34 ident: CR17 article-title: A personalized microRNA microarray normalization method using a logistic regression model publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp655 – volume: 9 start-page: 512 year: 2009 end-page: 24 ident: CR24 article-title: Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy publication-title: Cell Metab doi: 10.1016/j.cmet.2009.05.005 – volume: 217 start-page: 809 year: 2008 end-page: 18 ident: CR43 article-title: The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1 publication-title: J Cell Physiol doi: 10.1002/jcp.21558 – volume: 10 start-page: 273 year: 2009 end-page: 84 ident: CR50 article-title: MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2 publication-title: Cell Metab doi: 10.1016/j.cmet.2009.08.015 – volume: 27 start-page: 1859 year: 2007 end-page: 67 ident: CR22 article-title: A microRNA signature of hypoxia publication-title: Mol Cell Biol doi: 10.1128/MCB.01395-06 – volume: 10 start-page: 295 year: 2008 end-page: 305 ident: CR23 article-title: Direct regulation of TWIST by HIF-1alpha promotes metastasis publication-title: Nat Cell Biol doi: 10.1038/ncb1691 – volume: 107 start-page: 6334 year: 2010 end-page: 9 ident: CR38 article-title: P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0911082107 – volume: 283 start-page: 15878 year: 2008 end-page: 83 ident: CR46 article-title: MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3 publication-title: J Biol Chem doi: 10.1074/jbc.M800731200 – volume: 224 start-page: 242 year: 2010 end-page: 9 ident: CR47 article-title: miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells publication-title: J Cell Physiol – volume: 71 start-page: 4640 year: 2011 end-page: 52 ident: CR9 article-title: HIF induces human embryonic stem cell markers in cancer cells publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-10-3320 – volume: 282 start-page: 2130 year: 2007 end-page: 4 ident: CR21 article-title: Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors publication-title: J Biol Chem doi: 10.1074/jbc.C600252200 – volume: 24 start-page: 565 year: 2005 end-page: 74 ident: CR64 article-title: Involvement of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells publication-title: J Exp Clin Cancer Res – volume: 68 start-page: 5540 year: 2008 end-page: 5 ident: CR35 article-title: Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-6460 – volume: 22 start-page: 1178 year: 2007 end-page: 82 ident: CR62 article-title: Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2007.04997.x – volume: 5 start-page: e10345 year: 2010 ident: CR52 article-title: MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU publication-title: PLoS One doi: 10.1371/journal.pone.0010345 – volume: 31 start-page: 4087 year: 2011 end-page: 96 ident: CR6 article-title: MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia publication-title: Mol Cell Biol doi: 10.1128/MCB.01276-10 – volume: 10 start-page: 858 year: 2004 end-page: 64 ident: CR44 article-title: Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 publication-title: Nat Med doi: 10.1038/nm1075 – volume: 358 start-page: 2039 year: 2008 end-page: 49 ident: CR41 article-title: Tumor angiogenesis publication-title: N Engl J Med doi: 10.1056/NEJMra0706596 – volume: 16 start-page: 1889 year: 2012 end-page: 99 ident: CR25 article-title: Hypoxia-inducible factor 1-mediated human GATA1 induction promotes erythroid differentiation under hypoxic conditions publication-title: J Cell Mol Med doi: 10.1111/j.1582-4934.2011.01484.x – volume: 104 start-page: 879 year: 2009 end-page: 86 ident: CR36 article-title: Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes publication-title: Circ Res doi: 10.1161/CIRCRESAHA.108.193102 – volume: 35 start-page: 856 year: 2009 end-page: 67 ident: CR5 article-title: Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation publication-title: Mol Cell doi: 10.1016/j.molcel.2009.09.006 – volume: 6 start-page: 389 year: 2000 end-page: 95 ident: CR39 article-title: Mechanisms of angiogenesis and arteriogenesis publication-title: Nat Med doi: 10.1038/74651 – volume: 87 start-page: 431 year: 2010 end-page: 9 ident: CR57 article-title: Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4 publication-title: Cardiovasc Res doi: 10.1093/cvr/cvq082 – volume: 70 start-page: 2675 year: 2010 end-page: 85 ident: CR37 article-title: MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-09-2448 – volume: 284 start-page: 33161 year: 2009 ident: BFaps2012195_CR56 publication-title: J Biol Chem doi: 10.1074/jbc.M109.020925 – volume: 381 start-page: 335 year: 2004 ident: BFaps2012195_CR2 publication-title: Methods Enzymol doi: 10.1016/S0076-6879(04)81023-1 – volume: 9 start-page: 512 year: 2009 ident: BFaps2012195_CR24 publication-title: Cell Metab doi: 10.1016/j.cmet.2009.05.005 – volume: 72 start-page: 4629 year: 2012 ident: BFaps2012195_CR1 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-12-1383 – volume: 107 start-page: 6334 year: 2010 ident: BFaps2012195_CR38 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0911082107 – volume: 16 start-page: 4604 year: 1996 ident: BFaps2012195_CR42 publication-title: Mol Cell Biol doi: 10.1128/MCB.16.9.4604 – volume: 11 start-page: 407 year: 2007 ident: BFaps2012195_CR49 publication-title: Cancer Cell doi: 10.1016/j.ccr.2007.04.001 – volume: 8 start-page: S62 year: 2002 ident: BFaps2012195_CR3 publication-title: Trends Mol Med doi: 10.1016/S1471-4914(02)02317-1 – volume: 26 start-page: 228 year: 2010 ident: BFaps2012195_CR17 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp655 – volume: 28 start-page: 341 year: 2010 ident: BFaps2012195_CR28 publication-title: Nature Biotechnol doi: 10.1038/nbt.1618 – volume: 286 start-page: 43475 year: 2011 ident: BFaps2012195_CR8 publication-title: J Biol Chem doi: 10.1074/jbc.M111.284158 – volume: 358 start-page: 2039 year: 2008 ident: BFaps2012195_CR41 publication-title: N Engl J Med doi: 10.1056/NEJMra0706596 – volume: 461 start-page: 307 year: 2011 ident: BFaps2012195_CR4 publication-title: Pflugers Arch doi: 10.1007/s00424-010-0910-5 – volume: 71 start-page: 4720 year: 2011 ident: BFaps2012195_CR30 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-11-0365 – volume: 70 start-page: 2675 year: 2010 ident: BFaps2012195_CR37 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-09-2448 – volume: 71 start-page: 4640 year: 2011 ident: BFaps2012195_CR9 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-10-3320 – volume: 18 start-page: 465 year: 2011 ident: BFaps2012195_CR55 publication-title: Cell Death Differ doi: 10.1038/cdd.2010.119 – volume: 35 start-page: 856 year: 2009 ident: BFaps2012195_CR5 publication-title: Mol Cell doi: 10.1016/j.molcel.2009.09.006 – volume: 16 start-page: 230 year: 2010 ident: BFaps2012195_CR14 publication-title: Trends Mol Med doi: 10.1016/j.molmed.2010.03.004 – volume: 284 start-page: 35134 year: 2009 ident: BFaps2012195_CR51 publication-title: J Biol Chem doi: 10.1074/jbc.M109.052779 – volume: 54 start-page: 2064 year: 2011 ident: BFaps2012195_CR60 publication-title: Hepatology doi: 10.1002/hep.24614 – volume: 286 start-page: 2047 year: 2011 ident: BFaps2012195_CR12 publication-title: J Biol Chem doi: 10.1074/jbc.M110.158790 – volume: 28 start-page: 2719 year: 2009 ident: BFaps2012195_CR29 publication-title: EMBO J doi: 10.1038/emboj.2009.214 – volume: 435 start-page: 839 year: 2005 ident: BFaps2012195_CR20 publication-title: Nature doi: 10.1038/nature03677 – volume: 282 start-page: 2130 year: 2007 ident: BFaps2012195_CR21 publication-title: J Biol Chem doi: 10.1074/jbc.C600252200 – volume: 283 start-page: 15878 year: 2008 ident: BFaps2012195_CR46 publication-title: J Biol Chem doi: 10.1074/jbc.M800731200 – volume: 104 start-page: 879 year: 2009 ident: BFaps2012195_CR36 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.108.193102 – volume: 7 start-page: 255 year: 2008 ident: BFaps2012195_CR54 publication-title: Cancer Biol Ther doi: 10.4161/cbt.7.2.5297 – volume: 31 start-page: 2696 year: 2011 ident: BFaps2012195_CR33 publication-title: Mol Cell Biol doi: 10.1128/MCB.01242-10 – volume: 1 start-page: 779 year: 2005 ident: BFaps2012195_CR63 publication-title: Future Oncol doi: 10.2217/14796694.1.6.779 – volume: 224 start-page: 242 year: 2010 ident: BFaps2012195_CR47 publication-title: J Cell Physiol doi: 10.1002/jcp.22126 – volume: 10 start-page: 273 year: 2009 ident: BFaps2012195_CR50 publication-title: Cell Metab doi: 10.1016/j.cmet.2009.08.015 – volume: 27 start-page: 1859 year: 2007 ident: BFaps2012195_CR22 publication-title: Mol Cell Biol doi: 10.1128/MCB.01395-06 – volume: 10 start-page: 295 year: 2008 ident: BFaps2012195_CR23 publication-title: Nat Cell Biol doi: 10.1038/ncb1691 – volume: 16 start-page: 1889 year: 2012 ident: BFaps2012195_CR25 publication-title: J Cell Mol Med doi: 10.1111/j.1582-4934.2011.01484.x – volume: 68 start-page: 5540 year: 2008 ident: BFaps2012195_CR35 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-6460 – volume: 2 start-page: 795 year: 2002 ident: BFaps2012195_CR40 publication-title: Nat Rev Cancer doi: 10.1038/nrc909 – volume: 22 start-page: 1178 year: 2007 ident: BFaps2012195_CR62 publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2007.04997.x – volume: 24 start-page: 565 year: 2005 ident: BFaps2012195_CR64 publication-title: J Exp Clin Cancer Res – volume: 5 start-page: e10345 year: 2010 ident: BFaps2012195_CR52 publication-title: PLoS One doi: 10.1371/journal.pone.0010345 – volume: 217 start-page: 809 year: 2008 ident: BFaps2012195_CR43 publication-title: J Cell Physiol doi: 10.1002/jcp.21558 – volume: 7 start-page: e37537 year: 2012 ident: BFaps2012195_CR19 publication-title: PLoS One doi: 10.1371/journal.pone.0037537 – volume: 10 start-page: 858 year: 2004 ident: BFaps2012195_CR44 publication-title: Nat Med doi: 10.1038/nm1075 – volume: 31 start-page: 4760 year: 2011 ident: BFaps2012195_CR31 publication-title: Mol Cell Biol doi: 10.1128/MCB.05776-11 – volume: 6 start-page: e19139 year: 2011 ident: BFaps2012195_CR48 publication-title: PLoS One doi: 10.1371/journal.pone.0019139 – volume: 318 start-page: 944 year: 2012 ident: BFaps2012195_CR65 publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2012.02.010 – volume: 27 start-page: 1506 year: 2011 ident: BFaps2012195_CR18 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btr180 – volume: 29 start-page: 2638 year: 2010 ident: BFaps2012195_CR11 publication-title: Oncogene doi: 10.1038/onc.2010.23 – volume: 31 start-page: 4979 year: 2012 ident: BFaps2012195_CR26 publication-title: Oncogene doi: 10.1038/onc.2011.655 – volume: 72 start-page: 3631 year: 2012 ident: BFaps2012195_CR61 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-12-0667 – volume: 4 start-page: e7629 year: 2009 ident: BFaps2012195_CR13 publication-title: PLoS One doi: 10.1371/journal.pone.0007629 – volume: 6 start-page: e17167 year: 2011 ident: BFaps2012195_CR16 publication-title: PLoS One doi: 10.1371/journal.pone.0017167 – volume: 6 start-page: 389 year: 2000 ident: BFaps2012195_CR39 publication-title: Nat Med doi: 10.1038/74651 – volume: 31 start-page: 4087 year: 2011 ident: BFaps2012195_CR6 publication-title: Mol Cell Biol doi: 10.1128/MCB.01276-10 – volume: 87 start-page: 431 year: 2010 ident: BFaps2012195_CR57 publication-title: Cardiovasc Res doi: 10.1093/cvr/cvq082 – volume: 9 start-page: 1072 year: 2010 ident: BFaps2012195_CR15 publication-title: Cell Cycle doi: 10.4161/cc.9.6.11006 – volume: 29 start-page: 4362 year: 2010 ident: BFaps2012195_CR53 publication-title: Oncogene doi: 10.1038/onc.2010.193 – volume: 285 start-page: 20281 year: 2010 ident: BFaps2012195_CR58 publication-title: J Biol Chem doi: 10.1074/jbc.M110.109207 – volume: 8 start-page: 64 year: 2010 ident: BFaps2012195_CR10 publication-title: BMC Med doi: 10.1186/1741-7015-8-64 – volume: 69 start-page: 1221 year: 2009 ident: BFaps2012195_CR7 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-2516 – volume: 120 start-page: 4141 year: 2010 ident: BFaps2012195_CR34 publication-title: J Clin Invest doi: 10.1172/JCI42980 – volume: 12 start-page: 210 year: 2010 ident: BFaps2012195_CR27 publication-title: Breast Cancer Res doi: 10.1186/bcr2720 – volume: 270 start-page: 4515 year: 2003 ident: BFaps2012195_CR32 publication-title: Eur J Biochem doi: 10.1046/j.1432-1033.2003.03846.x – volume: 8 start-page: 2756 year: 2009 ident: BFaps2012195_CR59 publication-title: Cell Cycle doi: 10.4161/cc.8.17.9387 – volume: 93 start-page: 1074 year: 2003 ident: BFaps2012195_CR45 publication-title: Circ Res doi: 10.1161/01.RES.0000102937.50486.1B – reference: 22286762 - Oncogene. 2012 Nov 29;31(48):4979-86 – reference: 16556057 - Future Oncol. 2005 Dec;1(6):779-86 – reference: 19893619 - PLoS One. 2009;4(10):e7629 – reference: 18720385 - J Cell Physiol. 2008 Dec;217(3):809-18 – reference: 18059191 - Cancer Biol Ther. 2008 Feb;7(2):255-64 – reference: 19490906 - Cell Metab. 2009 Jun;9(6):512-24 – reference: 18297062 - Nat Cell Biol. 2008 Mar;10(3):295-305 – reference: 22962263 - Cancer Res. 2012 Sep 15;72(18):4629-41 – reference: 15944709 - Nature. 2005 Jun 9;435(7043):839-43 – reference: 19933824 - Bioinformatics. 2010 Jan 15;26(2):228-34 – reference: 20351690 - Nat Biotechnol. 2010 Apr;28(4):341-7 – reference: 20498629 - Oncogene. 2010 Jul 29;29(30):4362-8 – reference: 21555452 - Mol Cell Biol. 2011 Jul;31(13):2696-706 – reference: 22020939 - J Biol Chem. 2011 Dec 16;286(50):43475-85 – reference: 19721136 - J Biol Chem. 2009 Nov 27;284(48):33161-8 – reference: 18463380 - N Engl J Med. 2008 May 8;358(19):2039-49 – reference: 22655055 - PLoS One. 2012;7(5):e37537 – reference: 21347261 - PLoS One. 2011;6(2):e17167 – reference: 20885442 - Cell Death Differ. 2011 Mar;18(3):465-78 – reference: 17482131 - Cancer Cell. 2007 May;11(5):407-20 – reference: 21969601 - Mol Cell Biol. 2011 Dec;31(23):4760-74 – reference: 8756616 - Mol Cell Biol. 1996 Sep;16(9):4604-13 – reference: 20308559 - Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6334-9 – reference: 22387901 - Exp Cell Res. 2012 May 1;318(8):944-54 – reference: 10742145 - Nat Med. 2000 Apr;6(4):389-95 – reference: 17135268 - J Biol Chem. 2007 Jan 26;282(4):2130-4 – reference: 18417479 - J Biol Chem. 2008 Jun 6;283(23):15878-83 – reference: 20972335 - J Clin Invest. 2010 Nov;120(11):4141-54 – reference: 17559361 - J Gastroenterol Hepatol. 2007 Aug;22(8):1178-82 – reference: 20436681 - PLoS One. 2010;5(4):e10345 – reference: 21207057 - Pflugers Arch. 2011 Mar;461(3):307-15 – reference: 19265035 - Circ Res. 2009 Apr 10;104(7):879-86 – reference: 20404348 - J Biol Chem. 2010 Jun 25;285(26):20281-90 – reference: 20964835 - BMC Med. 2010;8:64 – reference: 21555366 - Cancer Res. 2011 Jul 1;71(13):4720-31 – reference: 19652553 - Cell Cycle. 2009 Sep 1;8(17):2756-68 – reference: 20219857 - Cardiovasc Res. 2010 Aug 1;87(3):431-9 – reference: 15063685 - Methods Enzymol. 2004;381:335-54 – reference: 19696742 - EMBO J. 2009 Sep 16;28(18):2719-32 – reference: 22050843 - J Cell Mol Med. 2012 Aug;16(8):1889-99 – reference: 20237418 - Cell Cycle. 2010 Mar 15;9(6):1072-83 – reference: 18632605 - Cancer Res. 2008 Jul 15;68(14):5540-5 – reference: 20233879 - Cancer Res. 2010 Apr 1;70(7):2675-85 – reference: 20232316 - J Cell Physiol. 2010 Jul;224(1):242-9 – reference: 14576200 - Circ Res. 2003 Nov 28;93(11):1074-81 – reference: 14622280 - Eur J Biochem. 2003 Nov;270(22):4515-22 – reference: 19808020 - Cell Metab. 2009 Oct;10(4):273-84 – reference: 15235597 - Nat Med. 2004 Aug;10(8):858-64 – reference: 12360282 - Nat Rev Cancer. 2002 Oct;2(10):795-803 – reference: 16471319 - J Exp Clin Cancer Res. 2005 Dec;24(4):565-74 – reference: 21067538 - Breast Cancer Res. 2010;12(5):210 – reference: 20154725 - Oncogene. 2010 May 6;29(18):2638-48 – reference: 21081489 - J Biol Chem. 2011 Jan 21;286(3):2047-56 – reference: 22144109 - Hepatology. 2011 Dec;54(6):2064-75 – reference: 22593189 - Cancer Res. 2012 Jul 15;72(14):3631-41 – reference: 21544242 - PLoS One. 2011;6(4):e19139 – reference: 20434954 - Trends Mol Med. 2010 May;16(5):230-7 – reference: 19782034 - Mol Cell. 2009 Sep 24;35(6):856-67 – reference: 17194750 - Mol Cell Biol. 2007 Mar;27(5):1859-67 – reference: 21498399 - Bioinformatics. 2011 Jun 1;27(11):1506-12 – reference: 19141645 - Cancer Res. 2009 Feb 1;69(3):1221-9 – reference: 21712410 - Cancer Res. 2011 Jul 1;71(13):4640-52 – reference: 11927290 - Trends Mol Med. 2002;8(4 Suppl):S62-7 – reference: 21807897 - Mol Cell Biol. 2011 Oct;31(19):4087-96 – reference: 19826008 - J Biol Chem. 2009 Dec 11;284(50):35134-43 |
SSID | ssj0032319 |
Score | 2.3969178 |
SecondaryResourceType | review_article |
Snippet | Hypoxia plays an important role in the tumor microenvironment by allowingthe development and maintenance of cancer cells, but the regulatory mechanisms by... Hypoxia plays an important role in the tumor microenvironment by allowing the development and maintenance of cancer cells, but the regulatory mechanisms by... |
SourceID | pubmedcentral proquest pubmed crossref springer chongqing |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 336 |
SubjectTerms | Biomedical and Life Sciences Biomedicine Cell Hypoxia - genetics Gene Expression Regulation Humans Hypoxia-Inducible Factor 1, alpha Subunit - genetics Hypoxia-Inducible Factor 1, alpha Subunit - metabolism Immunology Internal Medicine Medical Microbiology microRNA MicroRNAs - genetics Neoplasms - blood supply Neoplasms - genetics Neoplasms - metabolism Neovascularization, Pathologic - genetics Pharmacology/Toxicology Review Up-Regulation Vaccine 人类 小分子RNA 癌症 细胞周期调控 缺氧条件 缺氧诱导因子1 肿瘤细胞 |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwEB1BOcAF8d2UUhkJ9tKGOrETOydUVVQrJKoKtdLeLMdxYKWS3e5uJfbfM-N8LEsrznYcyzO2nz3j9wA-OK9szVUae0dPcjKv4rLwPhYIlWtE6L4OoZhv5_n4Sn6dZJPuwm3ZpVX2a2JYqKuZozvy40SQpqzC_frz_CYm1SiKrnYSGg_hUaAuQ39Wk-HAJRC7EPxNckXnJC26xHcu9LGdE1d3kn5KSFniMS41zY8b3Cy2t6c7mPNu6uQ_8dOwLZ09g6cdnmQnrQM8hwe-eQGji5aQen3ELjfvq5ZHbMQuNlTV65dwOF7PZ7-nNl60kvS-Yr8oQ-_7-cmSTRsWFPyYI89YvIKrsy-Xp-O4k0-IXSbTVYyT1dY6daLmlVO5T4lJBg90UlurdOGl9Rzhmcxrj7O6lnle1CoprRYll6WrxWvYaWaN3wVWOPwmqXiFTUnuZYmgx4vKZrrkzlU8gr1hBM28pckwMhOyUAUWHvZDalxHPE76F9cmBMCFNmgMQ8YwaIwIPg61-5bur7ffW8d0025pNk4SwfuhGCcMRUFs42e3bR1d4DFORfCmNebwo1QIYgTUEagtMw8ViIx7u6SZ_gyk3CLTCqF2BKPeIf7q1j393_t__9_CkzQIb1C22z7srBa3_h3Cn1V5EHz8D-m7A3U priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fT9swED4xeNnLtME2wthkpK0vNODETuw8ogpUIYHQBBJvluPYUImlXVuk9b_f2fnBOnjg2RfH8t3Z3-nO3wF8N1ZoR0UaW-Of5GRWxGVhbcwQKjtE6NaFVMzFZT6-4ee32e0GDLu3MKFoP1BahmO6qw471jPPrZ2kR0mRvYEtiRGdt-dRPurOXYZIxYPdJBc-KpKsLXOnTK597UkU7qf13W-8GtYvo2cI83mh5H_Z0nAJnb2Hdy16JCfNej_Ahq23YXDV0E-vhuT66TXVYkgG5OqJmHq1A4fj1Wz6Z6LjedOA3lbkl6_H-3l5siCTmoR-fcR4O5h_hJuz0-vROG6bJcQm4-kyRtfUTqaGOVoZkdvU88Zg-Mal1kIWlmtLEYzx3Fn0YcfzvHAiKbVkJeWlcewTbNbT2u4CKQx-k1S0wqk4tbxEiGNZpTNZUmMqGsFev4Nq1pBiKJ4xXogCBw-7LVWmpRn33S4eVEh3M6lQGcorQ6EyIvjRS3czvSy332lHtU62UAnzbYYFQrgIDvphdA-f89C1nT42MrLAoE1E8LlRZv-jlDHP_ycjEGtq7gU89fb6SD25DxTcLJMCgXUEg84g_lnWC-vfe63gF3ibhoYbvsptHzaX80f7FWHPsvwWrP0vn5f_bg priority: 102 providerName: Springer Nature |
Title | Hypoxia-regulated microRNAs in human cancer |
URI | http://lib.cqvip.com/qk/95561A/201303/45349790.html https://link.springer.com/article/10.1038/aps.2012.195 https://www.ncbi.nlm.nih.gov/pubmed/23377548 https://www.proquest.com/docview/1314517056 https://www.proquest.com/docview/1314892607 https://pubmed.ncbi.nlm.nih.gov/PMC3587916 |
Volume | 34 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ba9swFD708rKXsa67uOuCC1teWne2JVvSwxhJaAiDhlAayJuQZXkNdE6apND8-x751qbNQ58MlmQLHR3OdzjS9wH80IapzGehZ7S9khMZ5iXCGI8gVM4QoZusKMVcDuPBmP6dRJMdqNVGqwVcbk3trJ7UeHF7_nC3_oMO_7u8Ms5_qbnl3Q7C80BEu7CPMSm2adglbeoJBFGMKK9GWvHWiFZH4F-OtgQLN7P83x2Gjc1A9Qp9vj5E-aKSWgSo_gd4XyFLt1NuhQPYMflHaI9Kaur1mXv9dNNqeea23dETafX6EE4H6_nsYaq8RSlOb1L3vz2rdzXsLN1p7hZafq62e2TxCcb9i-vewKuEFDwd0XDloduqjIeaZH6qWWxCyymDqR3lSjEuDFXGR6BG48ygf2c0jkXGgkRxkvg00Rn5DHv5LDdfwRUaxwSpn-KnqG9ogvDHkFRFPPG1Tn0HjpoVlPOSMEPSiFDBBDae1ksqdUVBbpUwbmVRCidcojGkNYZEYzjws-ldf2l7v-PaOrLePzIgVoKYIbxz4KRpRtex9RCVm9l92YcLTOiYA19KYzY_Cgmx3IDcAbZh5qaDpeXebMmnNwU9N4k4Q9DtQLveEM-mtWX-R2-Y4Dd4FxY6HPbw2zHsrRb35juioVXSgl02YS3Y7_S73SE-uxfD0RW-7cW9VuEEj1XLDNM |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fT9swED6x8sBepv1eGNsyafQFMpLYiZ2HaWIbqAyoKlQk3ozjOKwSpKUt2vpP7W_cXX6060B749muY_nO9ufe3fcBfDBW6NwXoWcNleREVnhpYq3HECrniNBtXoZijrtx55R_P4vOVuB3UwtDaZXNmVge1NnQ0H_kOwEjTVmB9_Xn0bVHqlEUXW0kNCq3OLSzn_hkm3w6-Ib23QzD_b3-145Xqwp4JuLh1EMf1rkMDcv9zIjYhkSwgu8cLrUWMrFcWx9RC49zi86e8zhOchGkWrLU56nJGY77AFY5VbS2YPXLXrd30pz9DNESAe4gFvQyk6xOtfeZ3NEjYgcPwo8BaVms4eFWXFzj9bR8Id5CubeTNf-J2JYX4f5jeFQjWHe3crknsGKLp9DuVRTYs223v6jommy7bbe3IMeePYOtzmw0_DXQ3thekHKYzdwrygk86e5O3EHhlpqBriFfHD-H03tZ2hfQKoaFfQVuYvA3QeZnOBT3LU8RZlmW6UimvjGZ78D6fAXVqCLmUDxiPBEJNm41S6pMTXVOihuXqgy5M6nQGIqModAYDmzOezcj3d1vo7GOqjf6RC3c0oH382bcohR30YUd3lR9ZIIPR-HAy8qY8w-FjBEHoXRALJl53oHov5dbisGPkgacRVIguHeg3TjEX9O6Y_7r_5__O1jr9I-P1NFB9_A1PAxL2Q_KtduA1nR8Y98g-Jqmb2uPd-H8vjfZH7gKQNo |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NIQEviG8yBhiJ9WULTWIndh4QmhhVx6Cq0Cb1zTiOPSptadd2gv5r_HWc81XKJt727Ktj-e7s3_XOvwN4qw1XNuCRb7R7khMb7mepMT5FqGwRoRtbpmK-DpL-Cfs8ikcb8Lt5C-PKKpszsTyo84l2_5F3Q-p6ynK8r7u2LosYHvQ-TC9810HKZVqbdhqViRyZ5U8M3-bvDw9Q1ztR1Pt0_LHv1x0GfB2zaOGjPSsrIk1tkGuemMiRrWDMw4RSXKSGKRMggmGJNWj4liVJanmYKUGzgGXaUpz3FtzmFFEV-hIftcEeRdzkoHeYcBejCVoX3QdUdNXU8YSH0bvQdbW4i8dccXqBF9X61XgF714t2_wnd1teib0HcL_GsmS_Mr6HsGGKR9AZVmTYyz1yvHrbNd8jHTJc0WQvH8Nufzmd_Borf2ZOXQ8xk5NzVx34bbA_J-OClN0DiXZWOXsCJzeysU9hs5gU5jmQVONvwjzIcSoWGJYh4DI0V7HIAq3zwIOtdgfltKLokCymLOUpDu42Wyp1TXruem-cyTL5ToVEZUinDInK8GCnlW5mul5uu9GOrF1-LlcG6sGbdhid1WVgVGEml5WMSDGE5B48q5TZfiii1LERCg_4mppbAUcEvj5SjH-UhOA0FhxhvgedxiD-WtY169_6__pfwx10LfnlcHD0Au5FZf8PV3S3DZuL2aV5iShskb0qzZ3A95v2rz8L2kOh |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hypoxia-regulated+microRNAs+in+human+cancer&rft.jtitle=Acta+pharmacologica+Sinica&rft.au=Shen%2C+Guomin&rft.au=Li%2C+Xiaobo&rft.au=Jia%2C+Yong-feng&rft.au=Piazza%2C+Gary+A&rft.date=2013-03-01&rft.issn=1745-7254&rft.eissn=1745-7254&rft.volume=34&rft.issue=3&rft.spage=336&rft_id=info:doi/10.1038%2Faps.2012.195&rft.externalDBID=NO_FULL_TEXT |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F95561A%2F95561A.jpg |